en

PRODUCT DETAIL

Velsipity 2 mg filmom obalené tablety

Code 5649E
MA number EU/1/23/1790/001
Product Form: tbl flm 28x2 mg (blis.Al/OPA/HDPE/LDPE/papier)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AE Sphingosine 1-phosphate (S1P) receptor modulators
L04AE05 Etrasimod
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.02.2024
Validity: 16.02.2029
Safety feature Yes
Data update: 23.02.2024
eu-flag.png sk-flag.png